Were looking for individuals who: Are 5570 years old Have a BMI 30, or 27 with a weight-related condition (like high blood pressure, diabetes, or high cholesterol) Have been on a stable dose of medications (if any) for at least 12 weeks Are not using insulin or planning to start an intensive weight-loss or exercise program Are not pregnant or planning pregnancy (see details below) If this sounds like you, you could help us explore a whole new approach to healthy aging
If youre switching at an equivalent dose, no
How the Semaglutide/Cyanocobalamin Combination Enhances Weight Loss When combined, semaglutide and cyanocobalamin offer a multi-faceted approach to weight loss
Last year, the American healthcare industry spent $38.6 billion on semaglutide (Ozempic, Wegovy, Rybelsus), and $13.2 billion on tirzepatide (Mounjaro, Zepbound)
Participants received tirzepatide at 5,10, or 15 mg doses or a placebo control